Kiromic BioPharma, Inc. (KRBP)
OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
As of 09:48AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 4.94M |
| Enterprise Value | 14.84M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 11.55 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.13 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change 3 | 16.36% |
| S&P500 52-Week Change 3 | 23.49% |
| 52 Week High 3 | 4.0800 |
| 52 Week Low 3 | 0.1600 |
| 50-Day Moving Average 3 | 2.7942 |
| 200-Day Moving Average 3 | 1.5767 |
Share Statistics
| Avg Vol (3 month) 3 | 3.48k |
| Avg Vol (10 day) 3 | 3.02k |
| Shares Outstanding 5 | 1.54M |
| Implied Shares Outstanding 6 | 1.32M |
| Float 8 | 963.16k |
| % Held by Insiders 1 | 30.81% |
| % Held by Institutions 1 | 0.00% |
| Shares Short (Aug 31, 2023) 4 | 45.74k |
| Short Ratio (Aug 31, 2023) 4 | 1.45 |
| Short % of Float (Aug 31, 2023) 4 | 6.82% |
| Short % of Shares Outstanding (Aug 31, 2023) 4 | 3.89% |
| Shares Short (prior month Jul 31, 2023) 4 | 62.44k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:30 |
| Last Split Date 3 | Mar 13, 2023 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -98.48% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -18.05M |
| Net Income Avi to Common (ttm) | -24.35M |
| Diluted EPS (ttm) | -7.4200 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.68M |
| Total Cash Per Share (mrq) | 2.82 |
| Total Debt (mrq) | 13.58M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.29 |
| Book Value Per Share (mrq) | -5.53 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22.8M |
| Levered Free Cash Flow (ttm) | -15.57M |
© 2024 Yahoo. All rights reserved.